Shots: The study evaluates the LUNAR-2 test in 699 patients with early-stage Stage 1, 2, or 3 CRC which showed a 96% overall sensitivity & 94% specificity. The test is […]readmore
Shots: Hologic to acquire Bolder Surgical for ~$160M which is a provider of advanced energy vessel sealing surgical devices. The acquisition is expected to be closed by 2021 The transaction will add […]readmore
Shots: The company has initiated the ORACLE study evaluating Guardant Reveal liquid biopsy test in 1000 patients with early-stage cancer after curative-intent treatment across 11 solid tumor types The study […]readmore
Shots: The US FDA has granted premarket approval of TransMedics’s OCS liver system for use with organs from DBD and DCD. The approval is based on the results of the […]readmore
Shots: The company has received CE Mark for its radial artery access portfolio including Rist 079 radial access guide catheter and Rist radial access selective catheter to treat patients with […]readmore
Shots: GE has signed an agreement to acquire BK Medical for $1.45B in cash and is eligible to receive a high-single-digit return on invested capital within 5yrs. The transaction is […]readmore
Shots: The US FDA has approved Abbott’s Epic Plus & Epic Plus Supra Stented Tissue valves to treat patients with aortic or MV disease who undergoes valve replacement surgery. The […]readmore
Shots: The US FDA has approved Abbott’s Portico with FlexNav TAVR system to treat patients with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery. […]readmore
Shots: ZOLL Medical to acquire all outstanding ordinary shares of Itamar Medical for $31/ADS or $1.03/ordinary share in cash making a total deal value of $538M representing a premium of […]readmore
Shots: The companies collaborated to develop a new AI algorithm called “basis profile curve identification.” for the improvement of brain stimulation devices to treat psychiatric illness & stroke Mayo Clinic […]readmore